Q: Does blinding matter in RCTs of surgical procedures? A: Depends on the endpoint JAMA Surgery

We compared placebo-controlled and open-label surgical trials to identify when the placebo effect is most powerful Rasha Al-Lamee Katie Thomas NHLI

jamanetwork.com/journals/jamas…

Many congratulations to Qiang Zhang - one of Oxford’s newest PIs!

Many congrats Zakariye Ashkir for winning the CMR 2024 ECA translational award. This is a really proud primary supervisor moment. Thank you to the British Heart Foundation SCMR and special thanks to Rina Ariga and Liz Tunnicliffe for the original ground work in this space.

Thanks #CMR2024 for the chance to present my work looking at Takotsubo syndrome and parametric mapping! RDM Oxford

Excellent series on AI and ML approaches in CMR. Here was a great talk by Mayooran Shan on risk prediction for patients using CMR indices after MI Sarah Moharem Elgamal, MBBCh, MSc, PhD👩🏻‍⚕️🫀 #CMR2024

Watching Ricardo A Gonzales at CMR 2024 - what a great talk!

We are #hiring for Postdoctoral researcher in AI deep learning for CMR imaging at University of Oxford. Message me if you're interested in joining our team. We are attending CMR 2024: The Global CMR Conference if you would like to meet! #CMR2024 - via #Whova event app

Congrats, Evangelos K. Oikonomou for ASCI Emerging-Generation Award!

A well-deserved recognition of your amazing hard work and creativity! CarDS Lab Yale Cardiology

Harlan Krumholz Eric J Velazquez

Metabolic dysfunction in Aortic Stenosis: A key piece of the pathophysiological puzzle.
So proud to share our research work on #aorticstenosis #whyCMR
Oliver Rider SaulMyerson RDM Oxford British Heart Foundation

Very pleased to share our latest work looking at the importance of sex-specific reference ranges for T1 and T2 mapping!

I am standing for BCS Women in Cardiology lead!
🚨final 24h of voting for all members of British Cardiovascular Society
✅help me making my role obsolete
BCS Women in Cardiology #CardioTwitter

DF% on 4D flow CMR may be a valuable target for the therapeutic monitoring of disease-specific therapies (myosin ATPase inhibitors, gene therapies) in non-obstructive HCM. bit.ly/40NY9kc RDM Oxford Society for Cardiovascular Magnetic Resonance EHJ Editor-in-Chief Congrats Zakariye Ashkir, on this important work.

The CMR Board Exam Review Course is almost here! The course will start this Saturday, 1 April at 8:00 (PDT) / 11:00 (EDT) / 16:00 (BST). We look forward to seeing you there!

Great podcast with the inspiration that is Dr Ayisha Khan-Kheil!

Great work led by Henry W. West and Charis Antoniades - There is so much information hidden in the epicardial adipose tissue phenotype; more data demonstrating how AI can transform CT #yesCCT into a powerful risk stratification tool in cardiometabolic disease.

Great to present my work on T1 mapping and the importance of sex-specific normal ranges at SCMR in San Diego! #scmr23 #WIC #OCMR

Good job, Omar!

Proud to be part of a great team working on this exciting project!

Excited to have our VNE work published in Circulation Circulation: AI-powered Virtual Native Enhancement (VNE) of CMR can assess myocardial infarction scar without IV contrasts. A joint effort with Matt Burrage Mayooran Shan and team RDM Oxford ahajournals.org/doi/10.1161/CI…

🚨🚨 #EHJCaseReports applications open for our training programmes🧑‍🎓👩‍🎓:
1⃣Associate Editor 📰
2⃣Junior Reviewer 📝
3⃣Junior Editors 💻
4⃣Podcast Editors 🎙️

⏰4th July

➡️Apply: tinyurl.com/26psu5pb
➡️More details: academic.oup.com/ehjcr/pages/ed…
➡️Testimonials: EHJCaseReports Editor-in-Chief